The civil Racketeer Influenced and Corrupt Organizations Act (“RICO”) statute, 18 U.S.C. § 1964(c), was originally enacted as a tool for fighting organized crime. The civil RICO statute allows recovery of treble damages for persons injured…
He “took an idea about the law – the importance of assuring that sound science and research be required in our state and federal courts – and made it the law of the land.”
The Firm congratulates fifteen attorneys named as 2023 Super Lawyers and Rising Stars for Washington, DC. The annual publication lists the top five percent of attorneys in each state, as chosen by their peers through a…
Firm founder Joe G. Hollingsworth is serving as a member of the Steering Committee for DePauw University’s Rector Scholarship Centennial. 2019 marks the centennial year of Edward and Lucy Rowland Rector’s historic scholarship gift in 1919,…
On June 2, 2017, the Third Circuit unanimously affirmed a decision excluding expert causation testimony and granting summary judgment in favor of Pfizer on claims that its anti-depressant drug Zoloft can cause cardiac birth defects if…
H.(T.) v. Novartis Pharm. Corp., No. S233898, -- P.3d --, 2016 WL 3192406 (Cal. June 8, 2016)
In October, firm founder Joe Hollingsworth gave the keynote address to the reunion weekend gathering of the Barristers’ Council at Georgetown Law. The Barristers’ Council, consisting of the law school’s mock trial, moot court, and alternative…
On June 23, 2015, the Firm hosted a DePauw University alumni event, the alma mater of Firm founder Joe G. Hollingsworth. Among the guests was Bret Baier, Chief Political Anchor at Fox News Channel, also a…
On Friday, May 22, 2015, Firm client Volvo Powertrain filed its reply brief in support of a petition for certiorari seeking U.S. Supreme Court review of EPA’s unauthorized exercise of extraterritorial enforcement authority to impose $62 million…
Notwithstanding the acknowledged territorial limits on its enforcement authority, EPA fined Volvo over $62 million for nonroad engines that were both manufactured and sold abroadon the ground that they did not meet EPA’s emission standards. On…
The Law Firm Challenge is an annual fundraising competition in which participating firms vie for the highest percentage of alumni giving and most dollars raised for Georgetown Law. Established as the first of its kind in…
"...a sparkling victory for DynCorp Inc. and its attorneys at the Hollingsworth firm."
This week The National Law Journal named Hollingsworth LLP for the third time to its Midsize Firm Hot List, an annual list that recognizes just twenty of the country’s midsize firms. Recognizing the Firm’s continued…
On two consecutive days, two different federal juries returned defense verdicts in favor of Firm client Novartis Pharmaceuticals Corporation in trials arising out of the federal MDL litigation pending in the Middle District of Tennessee, In re…
After less than five hours of deliberation, a Brooklyn, New York federal jury on May 25, 2011, returned a verdict in favor of Novartis Pharmaceuticals Corporation in a seven-day trial involving Aredia® and Zometa®, bisphosphonate drugs…
The United States District Court for the Middle District of Tennessee today granted Novartis Pharmaceutical Corporation’s motion for summary judgment in Foster v. Novartis Pharmaceuticals Corp., 3:08-0932 (M.D. Tenn.). Mr. Foster alleged that his wife’s use…
Joe Hollingsworth will present Toxic Torts’ Hot Spots as the luncheon guest speaker, and Eric Lasker will join Tom Graves, ACA’s General Counsel, in discussing ACA’s Amicus Program.
After two hours of deliberation, a New Brunswick, New Jersey jury on October 6, 2010, returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia® and Zometa®, bisphosphonate drugs given…
In September 2010, the U.S. Court of Appeals for the Sixth Circuit reversed a $20.5 million jury verdict in favor of a plaintiff in the welding fume litigation, holding that the district court had abused its…
On April 1, 2010, Judge Jessica Mayer, Mass Tort Judge for the New Jersey Superior Court in Middlesex County, granted firm client Novartis Pharmaceutical Corporation summary judgment in Walsh v. Novartis Pharmaceutical Corporation. Click here to view opinion. Plaintiff…
On April 1, 2010, Judge Jessica Mayer, Mass Tort Judge for the New Jersey Superior Court in Middlesex County, granted firm client Novartis Pharmaceutical Corporation’s motion to exclude the testimony of plaintiff’s case-specific expert Dr. Joseph…
See more about the mission and significance of The Chesapeake Legal Alliance at their website.
On November 24, 2009, the United State Court of Appeals for the Sixth Circuit affirmed the grant of summary judgment in favor of firm client Novartis Pharmaceuticals Corporation in three cases brought by residents of Michigan…
On November 24, 2009, the United State Court of Appeals for the Sixth Circuit affirmed the grant of summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“NPC”) in five cases brought by plaintiffs who…
On November 23, 2009, Judge Mayer of New Jersey Superior Court held that New Jersey law governing punitive damages would apply to two of the Aredia® and Zometa® cases currently being worked up for trial. Firm…
Case No. 3:08-1157, Anderson. In the first wave of cases in the In re Aredia and Zometa Products Liability Litigation, Chief Judge Todd Campbell of the United States District Court for the Middle District of Tennessee granted summary…
In the first wave of cases in the In re Aredia and Zometa Products Liability Litigation, Chief Judge Todd Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment for firm…
On March 4, 2009, the Supreme Court ruled 6-3 that plaintiff Diana Levine could sue the drugmaker Wyeth for injuries she suffered after receiving the antinausea drug Phenergan. Click here to view the opinion. The medicine…
On December 2, 2008, Chief Judge Todd J. Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment to Firm client, Novartis Pharmaceuticals Corporation (NPC), in five lawsuits brought by…
On December 3, 2008, the federal Judicial Panel on Multidistrict Litigation issued an order transferring two actions pending against a Firm client, Novartis Pharmaceuticals Corporation (NPC), back to the Aredia®/Zometa® MDL over the objections of the…
On September 29, 2008, Chief Judge Todd J. Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment to Firm client, Novartis Pharmaceuticals Corporation (NPC), in a lawsuit alleging that…
On July 22, 2008, the Philadelphia County Court of Common Pleas granted C.R. Bard, Inc.’s (“Bard”) Motion to Dismiss Pursuant to Forum Non Conveniens and 42 Pa. C.S.A. § 5322(e) in the case of Murphy v. C.R. Bard, Inc.…
In April, 2008, four weeks into an anticipated three month trial, Norfolk Southern railroad and Avondale Mills agreed to settle a lawsuit arising from the January 6, 2005 train derailment in Graniteville, South Carolina. The confidential…
On October 26, 2007, Joe Hollingsworth presented Sandoz Pharmaceuticals Corporation’s appeal to the Supreme Court of Kentucky in Gunderson v. Sandoz Pharmaceuticals Corporation. Among the issues the court had agreed to hear: challenges to the trial…
On August 16, 2007, the United States District Court for the District of New Jersey denied plaintiff’s motion to remand in Ripley v. Sandoz, Inc., finding removal to be proper under 28 U.S.C. Sec. 1441(b) despite…
On July 26, 2007, the Court of Appeals for the First District of Texas (Houston) issued a major opinion confirming the requirement of science-based evidence of specific causation in asbestos bodily injury claims. Georgia-Pacific Corp. v. Stephens,…
In a 4-3 ruling, the Missouri Supreme Court rejected a public nuisance claim brought against former lead paint manufacturers by the City of St. Louis, holding that the City’s inability to identify the defendants that supplied…
Hollingsworth LLP will co-sponsor the ABA Section of Dispute Resolution Spring Conference, “ADR in Bloom: Politics and Collaboration in the Nation’s Capital,” on April 26, 2007, at the Omni Shoreham hotel in Washington, DC. Joe Hollingsworth…
In 2005, the U.S. Court of Appeals for the Eleventh Circuit issued its opinion vacating the judgment of the trial court and erasing an $18 million lost profits award against the Firm’s client, General Electric. GE…
The National Law Journal selected Hollingsworth LLP three times in seven years for its Top Ten Defense Wins list, including for its success in Crowson v. Davol, a major medical device trial in 2004. This complex…
Legal Times, Food and Drug Law Supplement (September 19, 2005) (Joe G. Hollingsworth and Eric G. Lasker)
Joe Hollingsworth, national trial and appellate counsel for Novartis Pharmaceuticals Corp. in the Parlodel litigation, is featured in a supplement to The American Lawyer and Corporate Counsel magazines, “The Future of Litigation.” The article, “Inexact Science”…
The U.S. Court of Appeals for the Eleventh Circuit unanimously affirmed the grant of summary judgment to client, Novartis Pharmaceuticals in Rider/Siharath v. Sandoz Pharm. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). This decision…
In March 2000, the U.S. District Court for the Western District of Oklahoma entered summary judgment for Sandoz Pharmaceuticals Corporation, holding that the plaintiff’s proffered expert testimony that Parlodel® caused her stroke was not scientifically reliable…
Following a two-day evidentiary Daubert hearing in Caraker v. Sandoz Pharm. Corp., 172 F. Supp. 2d 1046 (S.D. Ill. 2001), Judge J. Phil Gilbert granted Firm client Sandoz’s motion to exclude expert testimony of plaintiffs’ expert witnesses…
March 19, 2001by Emily Heller For litigators who defend, winning summary judgment is about as good as it gets. To many, it’s even more satisfying than a favorable jury verdict because it avoids the expense and…
BNA Toxics Law Reporter (1995) (Joe G. Hollingsworth)